Skip to main content
Clinical Trials/DRKS00003564
DRKS00003564Completed未知

Health Economic Evaluation of costs and benefits of a computer based program called Deprexis used for insured persons of the DAK (statutory health insurance) suffering from depression - Study Deprexis

D A K - GesundheitUnternehmen LebenVorstandsreferat Versorgungsforschung (0010 30)0 sites3,832 target enrollmentStarted: February 17, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
3,832

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • (a) At least a mild depression: PHQ-9 >= 5
  • (b) age of at least 18 years
  • (c) Informed Consent
  • (d) Insured by the DAK at least for one year and availabilty of costs one year before and one year after the treatment with Deprexis
  • (e) Access to the internet

Exclusion Criteria

  • Danger of suizidal tendencies; measured by item number 9 of the questionnaire PHQ-9 (value > 0)

Investigators

Sponsor
D A K - GesundheitUnternehmen LebenVorstandsreferat Versorgungsforschung (0010 30)

Similar Trials